Medicare Enrolled
Dr. Zahid Akram, MD
Optician · Hermitage, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Akram from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Akram?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Akram
Dr. Zahid Akram is an optician specialist in Hermitage, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Akram performed 997 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Akram received a total of $61,962 from 61 pharmaceutical and/or device companies across 1336 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Akram is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 31% volume in PA
$61,962 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗997
Medicare services
Top 31% in PA for optician
Not available
Unique patients (not deduplicated)
$119
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
285 | $84 | $143 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
136 | $70 | $150 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
115 | $280 | $525 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
96 | $54 | $95 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
86 | $123 | $193 |
| New patient office visit, complex (60-74 min) | 73 | $159 | $278 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
55 | $170 | $370 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
41 | $68 | $135 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
35 | $207 | $402 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $104 | $221 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
21 | $10 | $20 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
17 | $81 | $167 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
15 | $132 | $260 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$61,962
Total received (2018-2024)
Avg $8,852/year across 7 years
Top 5% in PA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
1,336
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$15,220
2023
$10,537
2022
$5,756
2021
$10,116
2020
$7,557
2019
$7,241
2018
$5,536
Payments by company (2024)
GENZYME CORPORATION
$11,208
MDD US Operations, LLC
$338
ABBVIE INC.
$274
UCB, Inc.
$260
Genentech USA, Inc.
$211
ARGENX US, INC.
$210
MITSUBISHI TANABE PHARMA AMERICA, INC.
$208
ACADIA Pharmaceuticals Inc
$191
Teva Pharmaceuticals USA, Inc.
$188
Celgene Corporation
$178
Neurocrine Biosciences, Inc.
$166
JAZZ PHARMACEUTICALS INC.
$159
Amgen Inc.
$139
SK Life Science, Inc.
$137
E.R. Squibb & Sons, L.L.C.
$130
Biogen, Inc.
$125
Genentech, Inc.
$109
Alexion Pharmaceuticals, Inc.
$107
Otsuka America Pharmaceutical, Inc.
$106
Novartis Pharmaceuticals Corporation
$98
Eisai Inc.
$85
Lilly USA, LLC
$83
Lundbeck LLC
$80
Amneal Pharmaceuticals LLC
$70
Grifols USA, LLC
$67
Neurelis, Inc.
$61
PFIZER INC.
$54
EMD Serono, Inc.
$54
Sumitomo Pharma America, Inc.
$41
Acorda Therapeutics, Inc
$36
Kyowa Kirin, Inc.
$34
GE HEALTHCARE
$13
Top 3 companies account for 77.7% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$38,535
Biogen, Inc.
$2,557
UCB, Inc.
$2,231
Teva Pharmaceuticals USA, Inc.
$2,190
Genentech USA, Inc.
$1,584
Novartis Pharmaceuticals Corporation
$1,042
Amgen Inc.
$1,031
Lilly USA, LLC
$930
EMD Serono, Inc.
$811
ACADIA Pharmaceuticals Inc
$748
Celgene Corporation
$726
SK Life Science, Inc.
$612
MDD US Operations, LLC
$561
Adamas Pharmaceuticals, Inc.
$502
AbbVie Inc.
$467
MITSUBISHI TANABE PHARMA AMERICA, INC.
$439
Neurelis, Inc.
$438
ARGENX US, INC.
$403
Janssen Pharmaceuticals, Inc
$387
Alexion Pharmaceuticals, Inc.
$353
PFIZER INC.
$340
Acorda Therapeutics, Inc
$315
ABBVIE INC.
$310
Lundbeck LLC
$291
NOVARTIS PHARMACEUTICALS CORPORATION
$285
US WorldMeds, LLC
$285
Biohaven Pharmaceuticals, Inc.
$272
Neurocrine Biosciences, Inc.
$247
Amneal Pharmaceuticals LLC
$242
E.R. Squibb & Sons, L.L.C.
$231
Otsuka America Pharmaceutical, Inc.
$215
Eisai Inc.
$186
Biohaven Pharmaceutical Holding Company Ltd.
$182
Allergan, Inc.
$161
Supernus Pharmaceuticals, Inc.
$160
JAZZ PHARMACEUTICALS INC.
$159
Sumitomo Pharma America, Inc.
$142
EISAI INC.
$119
Jazz Pharmaceuticals Inc.
$111
Avanir Pharmaceuticals, Inc.
$110
Genentech, Inc.
$109
Banner Life Sciences, LLC
$96
Harmony Biosciences LLC
$94
Kyowa Kirin, Inc.
$85
Impax Laboratories, Inc.
$71
BANNER LIFE SCIENCES, LLC
$68
Grifols USA, LLC
$67
Abbott Laboratories
$50
Amylyx Pharmaceuticals, Inc.
$48
Strongbridge US INC.
$44
TG THERAPEUTICS, INC.
$41
AstraZeneca Pharmaceuticals LP
$38
Bayer HealthCare Pharmaceuticals Inc.
$37
Mitsubishi Tanabe Pharma America, Inc.
$35
Avion Pharmaceuticals
$34
Zyla Life Sciences
$30
GE HealthCare
$27
SANOFI-AVENTIS U.S. LLC
$25
GE HEALTHCARE
$23
Vertical Pharmaceuticals, LLC
$17
Allergan Inc.
$16
Top 3 companies account for 69.9% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Betaseron · Briviact · COMIRNATY · COPAXONE · Cenobamate · DISEASE STATE · DUOPA · Dhivy · EMGALITY · EPIDIOLEX · EVUSHELD · Enspryng · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Gocovri · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · LEMTRADA · Leqembi · MAYZENT · MS DISEASE STATE · MYOBLOC · Mavenclad · NAMZARIC · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · Ocrevus · Ocrevus Zunovo · Ozanimod · Ponvory · QULIPTA · RADICAVA · RELEXXII · RELYVRIO · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · Soliris · TALTZ · TECFIDERA · TROKENDI XR · TYSABRI · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · XARELTO · XCOPRI · XOLAIR · Xadago · ZEPOSIA · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
97
County median income
$60,614
Nearest hospital to ZIP centroid (approximate)
SHARON REGIONAL MEDICAL CENTER
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Akram is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Akram experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Akram performed 285 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Akram receive payments from pharmaceutical companies?
Yes. Dr. Akram received a total of $61,962 from 61 companies across 1,336 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Akram's costs compare to other opticians in Hermitage?
Dr. Akram's average Medicare payment per service is $119. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Akram) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Hermitage
Browse opticians in Hermitage ranked by procedure volume and transparency data.
Highest volume
Top Opticians in PA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in PA
Which PA opticians receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology